Characteristics and outcomes of asthmatic outpatients with COVID-19 who receive home telesurveillance
Open Access
- 24 October 2022
- journal article
- research article
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 8 (4)
Abstract
Background: The prognosis of asthmatic outpatients with COVID-19 needs to be clarified. The objectives of this study were: 1) to investigate the characteristics and outcomes of asthmatic patients receiving initial ambulatory care and home monitoring for COVID-19 with Covidom, a telesurveillance solution; and 2) to compare the characteristics and outcomes between asthmatic and non-asthmatic patients.Methods: Inclusion criteria were age ≥18 years, suspected or confirmed COVID-19 diagnosis allowing initial ambulatory care, registration in Covidom between March 2020 and April 2021 and completion of the initial medical questionnaire. We compared clinical characteristics and outcomes between asthmatic and non-asthmatic patients, and we evaluated whether asthma was independently associated with clinical worsening (hospitalisation or death) within 30 days follow-up using a multivariate logistic regression model.Results: 33 815 patients met the inclusion criteria. Asthma was reported in 4276 (12.6%). The main comorbidities among asthmatic patients were obesity (23.1%), hypertension (12.7%) and diabetes (4.5%). As compared with non-asthmatic patients, asthmatic patients were more often female (70.0versus62.1%, pversus43.8 years, pversus17.6%, pversus4.2%, p=0.203) and no asthmatic patient died during follow-up (versus25 non-asthmatic patients, 0.1%; p=0.109). In multivariate analysis, asthma was independently associated with higher risk of clinical worsening (OR 1.23, 95% CI 1.04–1.44, p=0.013).Conclusion: In a large French cohort of patients receiving initial ambulatory care and home monitoring for COVID-19, asthma was independently associated with higher risk of clinical worsening although no asthmatic patient died within the 30 days follow-up.Keywords
Funding Information
- APHP-Fondation de France
This publication has 33 references indexed in Scilit:
- Risk factors for severity and mortality in adult COVID-19 inpatients in WuhanJournal of Allergy and Clinical Immunology, 2020
- Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017The Lancet Respiratory Medicine, 2020
- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, ChinaAllergy, 2020
- Home self-monitoring in patients with asthma using a mobile spirometry systemJournal of Asthma, 2020
- Late Breaking Abstract - Asthma prevalence and management in adults in France in 2018: ASTHMAPOP surveyEuropean Respiratory Journal, 2018
- Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: a population-based cohortThorax, 2012
- Confirmation of asthma in an era of overdiagnosisEuropean Respiratory Journal, 2010
- The CYMPLA trial. Mobile phone-based strrctrred intervention to achieve asthma control in patients with rncontrolled persistent asthma: a pragmatic randomised controlled trialPrimary Care Respiratory Journal, 2009
- Overdiagnosis of asthma in obese and nonobese adultsCanadian Medical Association Journal, 2008
- The prevalence of dysfunctional breathing in adults in the community with and without asthmaPrimary Care Respiratory Journal, 2005